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A 12-week exercise program performed during the  
second trimester does not prevent gestational diabetes  
in healthy pregnant women
Synopsis
Summary of: Stafne SN et al (2012) Regular exercise during 
pregnancy to prevent gestational diabetes. Obstet Gynecol 
119: 29–36. [Prepared by Nora Shields, CAP Editor.]
Question: Does a 12-week exercise program prevent 
gestational diabetes and improve insulin resistance in 
healthy pregnant women with normal body mass index 
(BMI)? Design: Randomised, controlled trial with concealed 
allocation and blinded outcome assessment. Setting: Two 
University hospitals in Norway. Participants: White adult 
women with a single fetus. High-risk pregnancies or diseases 
that would interfere with participation were exclusion 
criteria. Randomisation of 855 participants allocated 429 to 
the exercise group and 426 to a control group. Interventions: 
Both groups received written advice on pelvic ﬂoor muscle 
exercises, diet, and lumbo-pelvic pain. In addition, the 
intervention group participated in a standardised group 
exercise program led by a physiotherapist, once a week 
for 12 weeks, between 20 and 36 weeks gestation. The 
program included 30–35 minutes low impact aerobics, 
20–25 minutes of strength exercises using body weight 
as resistance and 5–10 minutes of stretching, breathing, 
and relaxation exercises. They were also encouraged to 
follow a 45-minute home exercise program at least twice a 
week. The control group received standard antenatal care 
and the customary information given by their midwife or 
general practitioner. Outcome measures: The primary 
outcomes were the prevalence of gestational diabetes, 
insulin resistance estimated by the homeostasis model 
assessment method (HOMA-IR), and fasting insulin and 
oral glucose tolerance tests at baseline and at the end of 
the training period. Fasting and 2-hour glucose levels were 
measured in serum by the routine methods. Gestational 
diabetes was diagnosed as fasting glucose level 2-hour 
value * 7.8 mmol/L. Secondary outcome measures were 
weight, BMI, and pregnancy complications and outcomes. 
Results: 702 participants completed the study. At the end 
of the 12-week program, there was no difference in the 
prevalence of gestational diabetes (25 (7%) of intervention 
group compared with 18 (6%) of control group), HOMA-
IR (–0.15, 95% CI –0.33 to 0.03), or oral glucose tolerance 
tests at 2 hours (–0.13 mmol/L, 95% CI –0.28 to 0.03) 
between the groups. Fasting insulin was signiﬁcantly 
lower in the intervention group by 1.0 international units/
mL (95% CI –0.1 to –1.9). The groups did not differ 
signiﬁcantly on any of the secondary outcomes. Adherence 
to the exercise protocol in the intervention group was 55%. 
A per protocol analysis of 217 women in the intervention 
group who adhered to the exercise program demonstrated 
similar results with no difference in prevalence of diabetes. 
Conclusion: A 12-week exercise program undertaken 
during the second trimester of pregnancy did not reduce the 
prevalence of gestational diabetes in pregnant women with 
BMI in the normal range.
Commentary
Diabetes causes 5% of deaths worldwide, mainly in low-
to-middle income countries and affects over 220 million 
people. About 60% of women with gestational diabetes 
mellitus (GDM) are at high-risk of developing Type 
2 diabetes within 20 years (Boerschmann et al 2010). 
Current guidelines (Artal and O’Toole 2003) recommend 
regular exercise for pregnant women, including those 
who are sedentary. However, the effect of exercise on the 
development of GDM has been studied little, and the results 
of published studies are conﬂicting (Callaway et al 2010).
Stafne et al (2012) have presented a paper of excellent 
methodological quality, reported according to CONSORT, 
and dealing with the controversial question of exercise 
during pregnancy. In this trial, the incidence of GDM 
was similar in both groups and levels of insulin resistance 
(HOMA-IR) also showed no difference between groups, 
regardless of adjustment for factors such as baseline fasting 
insulin levels. Of note, only 55% of women in the exercise 
group adhered to the study protocol and 10% of women in 
the control group exercised at least three days per week. 
An exploratory analysis, in which adherent women in the 
exercise group were compared with women in the control 
group, showed no difference in incidence of GDM, but 
fasting insulin was lower in the adherent women. Given 
that the trial was not powered to compare adherent and non 
adherent women, results of the exploratory analysis should 
be interpreted with caution.
The lack of adherence to the exercise protocol among the 
study participants conﬁrms a pressing priority in this area 
is effective promotion of exercise in pregnant women. It is 
unclear whether the effect on GDM alone is large enough for 
pregnant women to feel it justiﬁes the time, effort, and cost of 
an exercise program. Other trials should determine whether 
any speciﬁc type of exercise before pregnancy prevents 
GDM. Despite the uncertainty about whether exercise 
during pregnancy prevents GDM, exercise provides other 
beneﬁts such as reducing depressive symptoms (Robledo-
Colonia 2012) suggesting we should continue prescription 
of exercise during pregnancy. A potentially successful 
strategy to encourage pregnant women to exercise might 
be to introduce regular leisure-time physical activity as a 
routine part of obstetric care (Ramírez-Velez et al 2011).
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